Purpose

Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.

Conditions

Eligibility

Eligible Ages
Between 20 Years and 40 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Between the ages of 20-40 years - Have a BMI ≤34.5 kg/m2 - are less than 72 in (182.88 cm) height - Nonsmoker

Exclusion Criteria

  • Diagnosis of Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD) - History or evidence of hepatic disease, hematological disease, or peripheral vascular disease; severe kidney injury requiring hemodialysis - History of cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia - Uncontrolled hypertension - History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease - Severe untreated obstructive sleep apnea - History of diabetes with HbA1c greater than 9.5 percent - Major neurologic disorders other than dementia (e.g., MS, ALS, brain surgery, etc.) - Current or recent (less than1 year) major psychiatric condition (Axis I) or addictive disorders - Significant surgical history - Other significant medical conditions at investigators' discretion - Contraindications to MRI - Prescribed medications that interfere with prazosin - Lactose allergy - lower body will not fit in lower body negative pressure (LBNP) chamber (regardless of overall height and BMI)

Study Design

Phase
Phase 2
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Young Adults
Young Adults between 20-40 years of age.
  • Device: MRI
    Participants will undergo an MRI scan while performing breathing and simulated postural change tasks.
  • Drug: Prazosin
    A dose of prazosin will be administered based on body weight
  • Drug: Placebo
    Oral placebo

Recruiting Locations

University of Wisconsin
Madison, Wisconsin 53705
Contact:
Anna J Howery, MS
608-262-9572
barneslab@education.wisc.edu

More Details

Status
Recruiting
Sponsor
University of Wisconsin, Madison

Study Contact

Anna Howery
608-262-9572
ahowery@wisc.edu

Detailed Description

Global cerebral blood flow (CBF) decreases with advancing age; however, some adults have accelerated declines in CBF, placing them at a greater risk of cognitive impairment. However, there is a lack of human studies that investigate the cause or consequence of altered blood flow regulation in the brain. This study will systematically address this gap in knowledge by examining cerebrovascular control in adults during acute physiological challenges (simulated postural change test and breathing increased carbon dioxide) that stimulate a change in CBF.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.